Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

Terumo Provides Update on Impact from Hurricane Maria

13/10/2017 - Tokyo, Japan

​Terumo Corporation (TSE: 4543) today provided an update on the impact to its manufacturing as a result of Hurricane Maria.

In the aftermath of Hurricane Maria, Terumo has been working diligently to assess the impact to its operations in Caguas, Puerto Rico, where Terumo manufactures the Angio-Seal™ Vascular Closure product line. The safety of 261 Terumo associates and their families located on the island remains Terumo's top priority. As of October 6, Terumo has accounted for 100% of the associates. Terumo's outreach to them is ongoing and Terumo is providing relief assistance to them.

Terumo has been suspending its manufacturing since September 20. The facility sustained minimal structural damage and Terumo is in the process of making repairs. Terumo is doing everything possible to return to normal operations and provide the Angio-Seal™ family of products to its customers and patients.

The impact of the disaster on Terumo's business performance is being examined. Further details regarding the impact will be disclosed, as needed, once the analysis is completed.


About Terumo Corporation

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.

 

(Notice) Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition. The market share information in this press release is partly derived from our own independent research.